slides · global inventory
Complication
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 25,056
Current window 16,231-16,260
Pages 836
Rows per page 30
Beat
16,231-16,260 of 25,056
04
The slide uses a citation from Schroeder (2007) to validate the claim.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
Uses a split-screen layout with a quote on the left and data points on the right.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The table uses a waterfall-style logic to explain the variance between two periods.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
3M | Results Presentation Deck | 20 slides3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
The slide serves as a visual index for the company's business units.3M | Results Presentation Deck | 20 slides · 3M
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
04
The slide uses a process-oriented timeline to break down drug development into three distinct phases with associated timeframes and complexity.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
05
The chart combines a line graph (investment/risk profile) with a bar chart (revenue/sales) over a 21-year timeline.AbCellera | Investor Conference Presentation Deck | 19 slides · AbCellera
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
05
The diagram illustrates the iterative, inefficient nature of conventional drug discovery (immunization/phage display) leading to suboptimal candidates.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide uses a two-column bulleted list to contrast the general AI drug discovery market with Absci's specific focus on biologics.Absci | Investor Presentation Deck | 27 slides · Absci
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide uses a human silhouette to map clinical manifestations to specific body systems.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Includes two testimonials from Key Opinion Leaders (KOLs) to emphasize the patient burden.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
The slide uses a pie chart to show patient segmentation by B6 responsiveness and a timeline/number line to show age of diagnosis, followed by key metrics on clinical complications.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
05
Includes footnotes regarding non-GAAP reconciliation and royalty revenue impacts from Janssen license agreement.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
06
Includes a highlighted column for Q1'23 and detailed footnotes regarding product licensing and arbitration.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
07
The slide includes a disclaimer regarding the date of the expectations and a note about non-GAAP reconciliation.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
08
Alkermes | Results Presentation Deck | 21 slidesAlkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
09
The chart illustrates the revenue contribution of four products: VIVITROL, ARISTADA, VUMERITY, and LYBALVI.Alkermes | Results Presentation Deck | 21 slides · Alkermes
Conference presentation Investor relations Beat · Need1 hit
12
Tesla Investor Day 2023 presentation slide.Tesla | Investor Day Presentation Deck | 163 slides · Tesla
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
13
Part of Tesla's Master Plan Part 3 presentation.Tesla | Investor Day Presentation Deck | 163 slides · Tesla
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
14
Part of Tesla's Master Plan Part 3 presentation.Tesla | Investor Day Presentation Deck | 163 slides · Tesla
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
15
Part of a larger presentation series on sustainability; includes a progress bar showing 5% reduction.Tesla | Investor Day Presentation Deck | 163 slides · Tesla
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
16
The slide uses three distinct waterfall charts to illustrate the scale of investment required across different sectors.Tesla | Investor Day Presentation Deck | 163 slides · Tesla
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
03
The slide uses a three-column layout to categorize ESG commitments.UBS | ESG Presentation Deck | 35 slides · UBS
Shareholder letter Investor relations Beat · ProblemLoop · Golden Circle1 hit
04
The slide uses a logo-grid layout to present ESG credentials.UBS | ESG Presentation Deck | 35 slides · UBS
Shareholder letter Investor relations Beat · ProblemLoop · Golden Circle1 hit
05
The chart highlights the 'Corporate Culture and Responsibility Committee' and the 'Sustainability and Climate Task Force' as key nodes.UBS | ESG Presentation Deck | 35 slides · UBS
Shareholder letter Investor relations Beat · ProblemLoop · Golden Circle1 hit
04
Vivid Seats | Results Presentation Deck | 23 slidesVivid Seats | Results Presentation Deck | 23 slides · Vivid Seats
Conference presentation Investor relations Beat · Problem1 hit
05
Vivid Seats | Results Presentation Deck | 23 slidesVivid Seats | Results Presentation Deck | 23 slides · Vivid Seats
Conference presentation Investor relations Beat · Problem1 hit
06
Vivid Seats | Results Presentation Deck | 23 slidesVivid Seats | Results Presentation Deck | 23 slides · Vivid Seats
Conference presentation Investor relations Beat · Problem1 hit
06
The chart uses a grouped bar chart format to compare two metrics across months.Yatsen | Results Presentation Deck | 19 slides · Yatsen
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit